US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Cullinan Therapeutics

7.76

+0.01000.13%

Post-market: 7.760.00000.00%16:34 EDT

Volume:1.44M

Turnover:11.22M

Market Cap:457.95M

PE:-2.51

High:7.98

Open:7.75

Low:7.63

Close:7.75

Loading ...

Overview Company News Filings

Cullinan Therapeutics Inc - Rezilient1 Trial Shows 35.2% Orr, 8.8 Months Mdor

THOMSON REUTERS

Cullinan Therapeutics Inc. to Participate in 2025 ASCO Annual Meeting and Jefferies Global Healthcare Conference

Cullinan Therapeutics: Promising Phase 2b Data and Strategic Partnerships Drive Buy Rating

Cullinan Therapeutics to present new results from REZILIENT1 trial

Cullinan Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary

Cullinan Oncology Is Maintained at Buy by UBS

UBS Adjusts Price Target on Cullinan Therapeutics to $24 From $30, Maintains Buy Rating

MT Newswires Live

Cullinan Therapeutics Reports Q1 2025 Financial Results

Promising Pipeline and Strategic Initiatives Drive Buy Rating for Cullinan Management

Cullinan Therapeutics Q1 Net Income USD -48.501 Million

Cullinan Therapeutics Q1 Net Income USD -48.501 Million

THOMSON REUTERS

Cullinan Therapeutics to Initiate US Study of CLN-978 for Moderate to Severe Sjogren's Disease

MT Newswires Live

Cullinan Therapeutics to Initiate Study of Cln-978, a Bispecific Cd19 T Cell Engager Administered Subcutaneously, in Patients With SjÖGren’s Disease in the United States

THOMSON REUTERS

Cullinan Therapeutics to Initiate Study of CLN-978, a Bispecific CD19 T Cell Engager Administered Subcutaneously, in Patients with Sjögren’s Disease in the United States

Cullinan Therapeutics to presents REZILIENT1 trial results at ASCO 2025

Cullinan Therapeutics to Present Results from REZILIENT1, a Phase 1/2 Trial of Zipalertinib in Patients with Non-Small Cell Lung Cancer Harboring EGFR Exon 20 Insertion Mutations Who Have Received Prior Therapy, at ASCO 2025

Promising Potential of Cullinan Management’s CLN-978 in Rheumatoid Arthritis Treatment Justifies Buy Rating

Cullinan Therapeutics Says EU Regulator Clears Phase 1 Rheumatoid Arthritis Trial

MT Newswires Live

Cullinan Management’s Promising Pipeline and Market Potential Justify Buy Rating and $33 Price Target

BRIEF-Cullinan Therapeutics Receives Approval From European Medicines Agency To Initiate Phase 1 Trial Of Cln-978

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/CGEM/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CGEM","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CGEM\",,,,,undefined,":{"symbol":"CGEM","market":"US","secType":"STK","nameCN":"Cullinan Therapeutics","latestPrice":7.76,"timestamp":1751054400000,"preClose":7.75,"halted":0,"volume":1444870,"hourTrading":{"tag":"盘后","latestPrice":7.76,"preClose":7.76,"latestTime":"16:34 EDT","volume":778492,"amount":6041103.463587,"timestamp":1751056483221},"delay":0,"floatShares":38999199,"shares":59014667,"eps":-3.09529,"marketStatus":"Market Closed","change":0.01,"latestTime":"06-27 16:00:00 EDT","open":7.75,"high":7.98,"low":7.63,"amount":11216839.34679,"amplitude":0.045161,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.09529,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1751270400000},"marketStatusCode":7,"adr":0,"listingDate":1610082000000,"exchange":"NASDAQ","adjPreClose":7.75,"postHourTrading":{"tag":"盘后","latestPrice":7.76,"preClose":7.76,"latestTime":"16:34 EDT","volume":778492,"amount":6041103.463587,"timestamp":1751056483221},"volumeRatio":4.020400403846649,"impliedVol":1.2744,"impliedVolPercentile":0.852},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CGEM\",,,,,undefined,":{"symbol":"CGEM","floatShares":38999199,"roa":"-25.38%","roe":"-36.57%","lyrEps":-3.112886,"volumeRatio":4.020400403846649,"shares":59014667,"dividePrice":0,"high":7.98,"amplitude":0.045161,"preClose":7.75,"low":7.63,"week52Low":6.85,"pbRate":"0.83","week52High":21.01,"institutionHeld":0,"latestPrice":7.76,"eps":-3.09529,"divideRate":0,"volume":1444870,"delay":0,"ttmEps":-3.09529,"open":7.75,"prevYearClose":12.18,"prevWeekClose":7.67,"prevMonthClose":8.645,"prevQuarterClose":7.57,"fiveDayClose":7.67,"twentyDayClose":8.68,"sixtyDayClose":7.5},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CGEM\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2540731030","title":"Cullinan Therapeutics Inc - Rezilient1 Trial Shows 35.2% Orr, 8.8 Months Mdor","url":"https://stock-news.laohu8.com/highlight/detail?id=2540731030","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540731030?lang=en_us&edition=fundamental","pubTime":"2025-06-01 20:23","pubTimestamp":1748780585,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250601:nFWN3S308Q:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CGEM","BK4139"],"gpt_icon":0},{"id":"2539254491","title":"Cullinan Therapeutics Inc. to Participate in 2025 ASCO Annual Meeting and Jefferies Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2539254491","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2539254491?lang=en_us&edition=fundamental","pubTime":"2025-05-29 19:00","pubTimestamp":1748516438,"startTime":"0","endTime":"0","summary":"Cullinan Therapeutics Inc., a biopharmaceutical company, will host a company event at the 2025 ASCO Annual Meeting in Chicago, IL, on June 1, 2025. The event will follow the oral presentation of results from the pivotal Phase 2b REZILIENT1 trial of zipalertinib in patients with EGFR exon20 insertion NSCLC. Additionally, the company will participate in the Jefferies 2025 Global Healthcare Conference, with presentations scheduled for June 4 and June 5, 2025, in New York, NY. Webcasts of these events will be available on the company's investor relations website.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cullinan Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire  on May 29, 2025, and i","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250529:nNDL1JRLKf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQF748.EUR","BK4139","LU2210149790.SGD","BK4588","IE00B3QW5Z07.USD","NDAQ","BK4585","IE00BKPKM429.USD","BK4112","LU2210150020.SGD","IE00B64PRP62.GBP","CGEM","LU2095319765.USD"],"gpt_icon":0},{"id":"2538496506","title":"Cullinan Therapeutics: Promising Phase 2b Data and Strategic Partnerships Drive Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2538496506","media":"TIPRANKS","labels":["corporation","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2538496506?lang=en_us&edition=fundamental","pubTime":"2025-05-28 01:25","pubTimestamp":1748366726,"startTime":"0","endTime":"0","summary":"Cullinan Management (CGEM – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Soumit Roy from ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/cullinan-therapeutics-promising-phase-2b-data-and-strategic-partnerships-drive-buy-rating?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/cullinan-therapeutics-promising-phase-2b-data-and-strategic-partnerships-drive-buy-rating?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CGEM"],"gpt_icon":0},{"id":"2537920108","title":"Cullinan Therapeutics to present new results from REZILIENT1 trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2537920108","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537920108?lang=en_us&edition=fundamental","pubTime":"2025-05-23 05:25","pubTimestamp":1747949117,"startTime":"0","endTime":"0","summary":"Cullinan Therapeutics (CGEM), Taiho Pharmaceutical and Taiho Oncology announced new results from the pivotal Phase 2b cohorts of the REZILIENT1 tri...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cullinan-therapeutics-to-present-new-results-from-rezilient1-trial-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cullinan-therapeutics-to-present-new-results-from-rezilient1-trial-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","CGEM"],"gpt_icon":0},{"id":"2535727943","title":"Cullinan Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2535727943","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535727943?lang=en_us&edition=fundamental","pubTime":"2025-05-13 20:00","pubTimestamp":1747137656,"startTime":"0","endTime":"0","summary":"Cullinan Therapeutics Inc reports results for the quarter ended March 31 - Earnings SummaryCullinan Therapeutics Inc CGEM.OQ reported a quarterly adjusted loss of 74 cents per share for the quarter en","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250513:nL8N3RL17N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CGEM"],"gpt_icon":0},{"id":"2535781022","title":"Cullinan Oncology Is Maintained at Buy by UBS","url":"https://stock-news.laohu8.com/highlight/detail?id=2535781022","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535781022?lang=en_us&edition=fundamental","pubTime":"2025-05-13 04:20","pubTimestamp":1747081200,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CGEM/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 12, 2025 16:20 ET (20:20 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CGEM"],"gpt_icon":0},{"id":"2534276459","title":"UBS Adjusts Price Target on Cullinan Therapeutics to $24 From $30, Maintains Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2534276459","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534276459?lang=en_us&edition=fundamental","pubTime":"2025-05-12 21:49","pubTimestamp":1747057742,"startTime":"0","endTime":"0","summary":"Cullinan Therapeutics (CGEM) has an average rating of buy and mean price target of $28.88, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from maj","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CGEM"],"gpt_icon":0},{"id":"2534077413","title":"Cullinan Therapeutics Reports Q1 2025 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2534077413","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534077413?lang=en_us&edition=fundamental","pubTime":"2025-05-10 12:18","pubTimestamp":1746850690,"startTime":"0","endTime":"0","summary":"Cullinan Management, Inc. ( ($CGEM) ) has released its Q1 earnings. Here is a breakdown of the information Cullinan Management, Inc. presented to i...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/cullinan-therapeutics-reports-q1-2025-financial-results?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/cullinan-therapeutics-reports-q1-2025-financial-results?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CGEM","BK4139"],"gpt_icon":0},{"id":"2534482725","title":"Promising Pipeline and Strategic Initiatives Drive Buy Rating for Cullinan Management","url":"https://stock-news.laohu8.com/highlight/detail?id=2534482725","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534482725?lang=en_us&edition=fundamental","pubTime":"2025-05-09 21:16","pubTimestamp":1746796571,"startTime":"0","endTime":"0","summary":"Analyst Julian Harrison of BTIG maintained a Buy rating on Cullinan Management (CGEM – Research Report), retaining the price target of $32.00. Juli...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/promising-pipeline-and-strategic-initiatives-drive-buy-rating-for-cullinan-management?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/promising-pipeline-and-strategic-initiatives-drive-buy-rating-for-cullinan-management?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CGEM"],"gpt_icon":0},{"id":"2533185833","title":"Cullinan Therapeutics Q1 Net Income USD -48.501 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2533185833","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533185833?lang=en_us&edition=fundamental","pubTime":"2025-05-08 19:16","pubTimestamp":1746703001,"startTime":"0","endTime":"0","summary":"May 08 (Reuters) - Cullinan Therapeutics Q1 operating expenses USD 54.996 million.:  ((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))  Source Date/Time = 08-MAY-202511:00:45.513 GMT","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250508:nRSD5Y6lrW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CGEM","BK4139"],"gpt_icon":0},{"id":"2533007189","title":"Cullinan Therapeutics Q1 Net Income USD -48.501 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2533007189","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533007189?lang=en_us&edition=fundamental","pubTime":"2025-05-08 19:00","pubTimestamp":1746702000,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250508:nPLX080219:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CGEM","BK4139"],"gpt_icon":0},{"id":"2531606754","title":"Cullinan Therapeutics to Initiate US Study of CLN-978 for Moderate to Severe Sjogren's Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2531606754","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531606754?lang=en_us&edition=fundamental","pubTime":"2025-04-29 22:59","pubTimestamp":1745938754,"startTime":"0","endTime":"0","summary":"Cullinan Therapeutics  said Tuesday that it is starting a US study of CLN-978 in patients with Sjogren's disease, a chronic autoimmune disease.The company said it will enroll patients with active, moderate to severe disease fulfilling the 2016 American College of Rheumatology classification criteria and who are positive for anti-Sjogren's syndrome-related antigen A/Ro antibodies and/or rheumatoid factor.The study will evaluate the safety and tolerability of CLN-978, while secondary objectives include pharmacokinetics, pharmacodynamics, immunogenicity, and effect on disease activity, according to Cullinan.The company said it expects to start the study in Q2.Shares of Cullinan were up 2.4% in recent trading.Price: 7.94, Change: +0.19, Percent Change: +2.39","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CGEM","BK4139"],"gpt_icon":0},{"id":"2531869107","title":"Cullinan Therapeutics to Initiate Study of Cln-978, a Bispecific Cd19 T Cell Engager Administered Subcutaneously, in Patients With SjÖGren’s Disease in the United States","url":"https://stock-news.laohu8.com/highlight/detail?id=2531869107","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531869107?lang=en_us&edition=fundamental","pubTime":"2025-04-29 19:03","pubTimestamp":1745924593,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250429:nFWN3R70WH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","CGEM"],"gpt_icon":0},{"id":"2531786662","title":"Cullinan Therapeutics to Initiate Study of CLN-978, a Bispecific CD19 T Cell Engager Administered Subcutaneously, in Patients with Sjögren’s Disease in the United States","url":"https://stock-news.laohu8.com/highlight/detail?id=2531786662","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531786662?lang=en_us&edition=fundamental","pubTime":"2025-04-29 19:00","pubTimestamp":1745924400,"startTime":"0","endTime":"0","summary":"CLN-978 is the first and only development-stage CD19 T cell engager to receive U.S. FDA IND clearance in autoimmune diseases. Sjgren’s disease represents the third indication under development for CLN-978, and is a disease with high unmet need and no currently approved therapies. CAMBRIDGE, Mass., April 29, 2025  -- Cullinan Therapeutics, Inc., a biopharmaceutical company focused on developing modality-agnostic targeted therapies, today announced that the Company is initiating a study of CLN-978 in patients with Sjgren’s disease  in the U.S. The Company previously received U.S. Food and Drug Administration  Investigational New Drug  Application clearance to study the CD19 T cell engager in patients with moderate to severe systemic lupus erythematosus  and European Medicines Agency  approval to study CLN-978 in active, difficult-to-treat rheumatoid arthritis.“There are an estimated four million Americans living with Sjgren’s disease, yet it is underdiagnosed","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cullinan-therapeutics-initiate-study-cln-110000913.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["SLE","BK4211","BK4077","BK4139","ACR","CGEM","UBCP","BK4110"],"gpt_icon":0},{"id":"2529163330","title":"Cullinan Therapeutics to presents REZILIENT1 trial results at ASCO 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2529163330","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529163330?lang=en_us&edition=fundamental","pubTime":"2025-04-23 22:20","pubTimestamp":1745418050,"startTime":"0","endTime":"0","summary":"Cullinan Therapeutics (CGEM) announced that results from the REZILIENT1 study of zipalertinib in non-small cell lung cancer patients with EGFR exon...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cullinan-therapeutics-to-presents-rezilient1-trial-results-at-asco-2025?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cullinan-therapeutics-to-presents-rezilient1-trial-results-at-asco-2025?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","CGEM"],"gpt_icon":0},{"id":"2529634536","title":"Cullinan Therapeutics to Present Results from REZILIENT1, a Phase 1/2 Trial of Zipalertinib in Patients with Non-Small Cell Lung Cancer Harboring EGFR Exon 20 Insertion Mutations Who Have Received Prior Therapy, at ASCO 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2529634536","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529634536?lang=en_us&edition=fundamental","pubTime":"2025-04-23 22:14","pubTimestamp":1745417640,"startTime":"0","endTime":"0","summary":"Cullinan and Taiho previously announced the Phase 2b portion of the study met the primary endpoint of overall response rate. Live and Virtual Investor EventCullinan will host an in-person event for analysts and institutional investors on Sunday, June 1, 2025, at 6:30 PM CDT, during which Danny Nguyen, MD, Assistant Clinical Professor, City of Hope National Medical Center, will participate in a discussion of the zipalertinib data shared at the 2025 ASCO Annual Meeting with members of Cullinan management. Participants from Cullinan Therapeutics include Nadim Ahmed, Chief Executive Officer, and Jeffrey Jones, MD, MBA, Chief Medical Officer.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cullinan-therapeutics-present-results-rezilient1-141400869.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","CGEM"],"gpt_icon":0},{"id":"2528792936","title":"Promising Potential of Cullinan Management’s CLN-978 in Rheumatoid Arthritis Treatment Justifies Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2528792936","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528792936?lang=en_us&edition=fundamental","pubTime":"2025-04-17 18:35","pubTimestamp":1744886143,"startTime":"0","endTime":"0","summary":"Julian Harrison, an analyst from BTIG, maintained the Buy rating on Cullinan Management (CGEM – Research Report). The associated price target remai...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/promising-potential-of-cullinan-managements-cln-978-in-rheumatoid-arthritis-treatment-justifies-buy-rating?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/promising-potential-of-cullinan-managements-cln-978-in-rheumatoid-arthritis-treatment-justifies-buy-rating?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CGEM"],"gpt_icon":0},{"id":"2527224577","title":"Cullinan Therapeutics Says EU Regulator Clears Phase 1 Rheumatoid Arthritis Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2527224577","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527224577?lang=en_us&edition=fundamental","pubTime":"2025-04-16 21:48","pubTimestamp":1744811289,"startTime":"0","endTime":"0","summary":"Cullinan Therapeutics  said Wednesday that the European Medicines Agency has approved its application to conduct a phase 1 clinical trial for CLN-978 to potentially treat rheumatoid arthritis.The biopharmaceutical company said the open-label trial will be initiated in Q2 to assess the safety, pharmacokinetics, pharmacodynamics, and effects of CLN-978 in patients with active, difficult-to-treat rheumatoid arthritis.Cullinan said the study will be held at FAU Erlangen-Nuremberg in Germany and Universita Cattolica del Sacro Cuore in Rome, the company added.Price: 7.70, Change: -0.10, Percent Change: -1.28","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4156","BK4139","CGEM"],"gpt_icon":0},{"id":"2527243501","title":"Cullinan Management’s Promising Pipeline and Market Potential Justify Buy Rating and $33 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2527243501","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527243501?lang=en_us&edition=fundamental","pubTime":"2025-04-16 21:35","pubTimestamp":1744810516,"startTime":"0","endTime":"0","summary":"Analyst Edward White of H.C. Wainwright reiterated a Buy rating on Cullinan Management (CGEM – Research Report), retaining the price target of $33....","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/cullinan-managements-promising-pipeline-and-market-potential-justify-buy-rating-and-33-price-target?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/cullinan-managements-promising-pipeline-and-market-potential-justify-buy-rating-and-33-price-target?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CGEM"],"gpt_icon":0},{"id":"2527292421","title":"BRIEF-Cullinan Therapeutics Receives Approval From European Medicines Agency To Initiate Phase 1 Trial Of Cln-978","url":"https://stock-news.laohu8.com/highlight/detail?id=2527292421","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527292421?lang=en_us&edition=fundamental","pubTime":"2025-04-16 19:17","pubTimestamp":1744802229,"startTime":"0","endTime":"0","summary":"BRIEF-Cullinan Therapeutics Receives Approval From European Medicines Agency To Initiate Phase 1 Trial Of Cln-978April 16 (Reuters) - Cullinan Therapeutics Inc CGEM.O:CULLINAN THERAPEUTICS RECEIVES AP","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250416:nFWN3QT2MF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CGEM"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":2,"totalSize":68,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CGEM\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-08","symbol":"CGEM","fiscalQuarterEnding":"2025/03","expectedEps":-0.78,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1746676800000,"reportTimeType":"pre","actualEps":-0.74},{"market":"US","date":"2025-02-27","symbol":"CGEM","fiscalQuarterEnding":"2024/12","expectedEps":-0.75,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1740632400000,"reportTimeType":"pre","actualEps":-0.73},{"market":"US","date":"2024-11-07","symbol":"CGEM","fiscalQuarterEnding":"2024/09","expectedEps":-0.78,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1730955600000,"reportTimeType":"pre","actualEps":-0.69},{"market":"US","date":"2024-08-08","symbol":"CGEM","fiscalQuarterEnding":"2024/06","expectedEps":-0.73,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1723089600000,"reportTimeType":"pre","actualEps":-0.75},{"market":"US","date":"2024-05-15","symbol":"CGEM","fiscalQuarterEnding":"2024/03","expectedEps":-0.9,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1715745600000,"reportTimeType":"post","actualEps":-0.86}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CGEM\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CGEM\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5,"buy":0.5,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.5,"analysts":10,"updateTime":1749700800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CGEM\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CGEM","date":"2025-06-27","current":-2.558878,"percent":0.736554,"low":-82.322021,"twenty":-13.795043,"median":-5.047979,"eighty":3.727137,"high":8.073957,"avg":-8.889313,"sd":15.398876,"marketCap":457363669},"quantilePoints":[{"date":"2021-01-08","current":-42.159039,"twenty":-39.647257,"median":-35.879584,"eighty":-32.11191,"marketCap":1181380603},{"date":"2021-01-15","current":-54.059463,"twenty":-54.429311,"median":-43.714306,"eighty":-41.524085,"marketCap":1514854272},{"date":"2021-01-22","current":-59.329798,"twenty":-58.297306,"median":-54.059463,"eighty":-42.159039,"marketCap":1662539609},{"date":"2021-01-29","current":-58.574692,"twenty":-58.836668,"median":-57.842701,"eighty":-43.714306,"marketCap":1641380014},{"date":"2021-02-05","current":-55.908703,"twenty":-58.574692,"median":-55.477214,"eighty":-51.979067,"marketCap":1566673689},{"date":"2021-02-12","current":-61.641349,"twenty":-59.021592,"median":-56.848734,"eighty":-52.040709,"marketCap":1727313880},{"date":"2021-02-19","current":-70.471472,"twenty":-59.573281,"median":-57.904342,"eighty":-52.17632,"marketCap":1974751593},{"date":"2021-02-26","current":-62.288583,"twenty":-64.649446,"median":-58.297306,"eighty":-52.641712,"marketCap":1745450675},{"date":"2021-03-05","current":-68.622232,"twenty":-66.859289,"median":-58.92913,"eighty":-53.797487,"marketCap":1922932176},{"date":"2021-03-12","current":-74.062081,"twenty":-69.115362,"median":-59.329798,"eighty":-54.429311,"marketCap":2075367626},{"date":"2021-03-19","current":-63.351896,"twenty":-69.435898,"median":-60.816896,"eighty":-55.286126,"marketCap":1775246840},{"date":"2021-03-26","current":-61.071166,"twenty":-68.856469,"median":-61.071166,"eighty":-55.748436,"marketCap":1711336226},{"date":"2021-04-01","current":-34.653954,"twenty":-68.683873,"median":-59.992443,"eighty":-54.336849,"marketCap":1795040156},{"date":"2021-04-09","current":-27.135096,"twenty":-68.159922,"median":-59.19881,"eighty":-52.016052,"marketCap":1405570837},{"date":"2021-04-16","current":-29.571374,"twenty":-67.759253,"median":-58.836668,"eighty":-38.821925,"marketCap":1531767600},{"date":"2021-04-23","current":-26.454618,"twenty":-67.207563,"median":-58.435999,"eighty":-32.103423,"marketCap":1370322776},{"date":"2021-04-30","current":-27.269511,"twenty":-66.742171,"median":-58.01992,"eighty":-29.588626,"marketCap":1412533417},{"date":"2021-05-07","current":-25.085262,"twenty":-66.252122,"median":-57.842701,"eighty":-28.74976,"marketCap":1299391492},{"date":"2021-05-14","current":-25.666496,"twenty":-65.857617,"median":-55.816241,"eighty":-27.43753,"marketCap":1203656017},{"date":"2021-05-21","current":-25.23037,"twenty":-65.632626,"median":-54.290618,"eighty":-27.279592,"marketCap":1183203438},{"date":"2021-05-28","current":-27.587308,"twenty":-65.16107,"median":-52.210223,"eighty":-27.215745,"marketCap":1293734396},{"date":"2021-06-04","current":-30.723706,"twenty":-64.778893,"median":-51.979067,"eighty":-27.125015,"marketCap":1440818898},{"date":"2021-06-11","current":-29.127669,"twenty":-64.091592,"median":-41.762192,"eighty":-27.188862,"marketCap":1365971163},{"date":"2021-06-18","current":-23.606496,"twenty":-62.926571,"median":-34.653954,"eighty":-26.976291,"marketCap":1107050220},{"date":"2021-06-25","current":-25.518028,"twenty":-62.220777,"median":-32.39833,"eighty":-26.455235,"marketCap":1196693437},{"date":"2021-07-02","current":-23.986946,"twenty":-61.940309,"median":-30.723706,"eighty":-26.30713,"marketCap":1124891831},{"date":"2021-07-09","current":-25.239649,"twenty":-61.666006,"median":-30.193045,"eighty":-25.598034,"marketCap":1183638600},{"date":"2021-07-16","current":-25.016947,"twenty":-61.527312,"median":-29.843385,"eighty":-25.527307,"marketCap":1173194730},{"date":"2021-07-23","current":-23.949829,"twenty":-60.932473,"median":-29.571374,"eighty":-25.232226,"marketCap":1123151186},{"date":"2021-07-30","current":-21.277396,"twenty":-60.300649,"median":-29.126896,"eighty":-25.016947,"marketCap":997824746},{"date":"2021-08-06","current":-25.629379,"twenty":-59.887653,"median":-28.951363,"eighty":-24.931577,"marketCap":1201915372},{"date":"2021-08-13","current":-22.380376,"twenty":-59.440752,"median":-28.633415,"eighty":-24.413811,"marketCap":1206526070},{"date":"2021-08-20","current":-22.727672,"twenty":-59.277403,"median":-28.428844,"eighty":-24.257774,"marketCap":1225248777},{"date":"2021-08-27","current":-23.131504,"twenty":-59.058577,"median":-27.914673,"eighty":-24.139127,"marketCap":1247019366},{"date":"2021-09-03","current":-23.38188,"twenty":-58.984607,"median":-27.587308,"eighty":-23.965013,"marketCap":1260517132},{"date":"2021-09-10","current":-23.220347,"twenty":-58.836668,"median":-27.513074,"eighty":-23.875524,"marketCap":1251808896},{"date":"2021-09-17","current":-21.338489,"twenty":-58.636333,"median":-27.214986,"eighty":-23.583796,"marketCap":1150357949},{"date":"2021-09-24","current":-18.616661,"twenty":-58.574692,"median":-27.118294,"eighty":-23.402351,"marketCap":1003624175},{"date":"2021-10-01","current":-19.98969,"twenty":-58.297306,"median":-26.862065,"eighty":-23.31266,"marketCap":1077644180},{"date":"2021-10-08","current":-19.238562,"twenty":-58.03533,"median":-26.455235,"eighty":-23.253883,"marketCap":1037150883},{"date":"2021-10-15","current":-20.191606,"twenty":-58.01992,"median":-26.399251,"eighty":-23.16109,"marketCap":1088529475},{"date":"2021-10-22","current":-17.938223,"twenty":-57.912047,"median":-26.295,"eighty":-22.956946,"marketCap":967049585},{"date":"2021-10-29","current":-17.946299,"twenty":-57.896637,"median":-25.647937,"eighty":-22.727672,"marketCap":967484997},{"date":"2021-11-05","current":-18.697427,"twenty":-57.788765,"median":-25.564424,"eighty":-22.146153,"marketCap":1007978293},{"date":"2021-11-12","current":-15.061427,"twenty":-55.908703,"median":-25.448433,"eighty":-21.588865,"marketCap":924801711},{"date":"2021-11-19","current":-13.851959,"twenty":-55.816241,"median":-25.23037,"eighty":-20.191606,"marketCap":850537993},{"date":"2021-11-26","current":-12.962645,"twenty":-55.545019,"median":-25.093663,"eighty":-19.655317,"marketCap":795932318},{"date":"2021-12-03","current":-11.532627,"twenty":-54.712861,"median":-25.016947,"eighty":-19.115797,"marketCap":708126393},{"date":"2021-12-10","current":-11.966613,"twenty":-54.151925,"median":-24.924154,"eighty":-18.93488,"marketCap":734773962},{"date":"2021-12-17","current":-11.141329,"twenty":-53.01156,"median":-24.696811,"eighty":-18.681274,"marketCap":684099896},{"date":"2021-12-23","current":-11.881239,"twenty":-52.425967,"median":-24.360449,"eighty":-18.48905,"marketCap":729531818},{"date":"2021-12-31","current":-10.977695,"twenty":-52.108515,"median":-24.274604,"eighty":-18.258058,"marketCap":674052452},{"date":"2022-01-07","current":-10.451221,"twenty":-52.003724,"median":-24.237487,"eighty":-17.965683,"marketCap":641725892},{"date":"2022-01-14","current":-9.73977,"twenty":-47.02021,"median":-24.135415,"eighty":-17.815458,"marketCap":598041352},{"date":"2022-01-21","current":-8.79354,"twenty":-43.092199,"median":-23.986946,"eighty":-17.447163,"marketCap":539940914},{"date":"2022-01-28","current":-9.135036,"twenty":-41.841562,"median":-23.956614,"eighty":-15.851137,"marketCap":560909493},{"date":"2022-02-04","current":-9.391159,"twenty":-38.821925,"median":-23.875524,"eighty":-14.251795,"marketCap":576635928},{"date":"2022-02-11","current":-9.675739,"twenty":-34.865658,"median":-23.638973,"eighty":-13.560264,"marketCap":594109744},{"date":"2022-02-18","current":-10.152412,"twenty":-34.576665,"median":-23.55082,"eighty":-12.62684,"marketCap":623378385},{"date":"2022-02-25","current":-10.316046,"twenty":-34.243987,"median":-23.422263,"eighty":-12.264,"marketCap":633425830},{"date":"2022-03-04","current":-9.199067,"twenty":-32.985537,"median":-23.365727,"eighty":-11.923926,"marketCap":564841102},{"date":"2022-03-11","current":-9.924747,"twenty":-31.341706,"median":-23.31266,"eighty":-11.764561,"marketCap":609399333},{"date":"2022-03-18","current":-9.068672,"twenty":-30.968679,"median":-23.264768,"eighty":-11.487094,"marketCap":594632811},{"date":"2022-03-25","current":-7.810079,"twenty":-30.630913,"median":-23.2365,"eighty":-11.193976,"marketCap":512106877},{"date":"2022-04-01","current":-7.476722,"twenty":-30.246402,"median":-23.166488,"eighty":-11.057378,"marketCap":490248656},{"date":"2022-04-08","current":-7.993765,"twenty":-30.188004,"median":-23.010354,"eighty":-10.59778,"marketCap":524151202},{"date":"2022-04-14","current":-7.619589,"twenty":-30.167842,"median":-22.956946,"eighty":-10.436992,"marketCap":499616465},{"date":"2022-04-22","current":-7.252216,"twenty":-29.88857,"median":-22.768055,"eighty":-10.316046,"marketCap":475527814},{"date":"2022-04-29","current":-6.699959,"twenty":-29.7982,"median":-22.622892,"eighty":-10.209328,"marketCap":439316344},{"date":"2022-05-06","current":-7.041446,"twenty":-29.600128,"median":-22.263264,"eighty":-10.059923,"marketCap":461707595},{"date":"2022-05-13","current":-7.253167,"twenty":-29.571374,"median":-21.928084,"eighty":-9.924747,"marketCap":475590171},{"date":"2022-05-20","current":-6.544416,"twenty":-29.520968,"median":-21.495984,"eighty":-9.689968,"marketCap":507833572},{"date":"2022-05-27","current":-6.625211,"twenty":-29.127669,"median":-21.277396,"eighty":-9.590365,"marketCap":514103122},{"date":"2022-06-03","current":-6.665609,"twenty":-29.126432,"median":-19.98969,"eighty":-9.496453,"marketCap":517237898},{"date":"2022-06-10","current":-6.971476,"twenty":-29.112513,"median":-19.577781,"eighty":-9.352741,"marketCap":540972624},{"date":"2022-06-17","current":-7.040729,"twenty":-28.982912,"median":-19.238562,"eighty":-9.13219,"marketCap":546346524},{"date":"2022-06-24","current":-7.727489,"twenty":-28.844515,"median":-19.109336,"eighty":-9.06676,"marketCap":599637701},{"date":"2022-07-01","current":-7.462019,"twenty":-28.737999,"median":-18.980109,"eighty":-8.81167,"marketCap":579037750},{"date":"2022-07-08","current":-8.218032,"twenty":-28.649627,"median":-18.867037,"eighty":-8.717851,"marketCap":637702828},{"date":"2022-07-15","current":-8.495044,"twenty":-28.533795,"median":-18.697427,"eighty":-8.386127,"marketCap":659198429},{"date":"2022-07-22","current":-8.396936,"twenty":-28.475112,"median":-18.548009,"eighty":-8.431562,"marketCap":651585404},{"date":"2022-07-29","current":-7.796742,"twenty":-28.344626,"median":-18.382438,"eighty":-8.277293,"marketCap":605011602},{"date":"2022-08-05","current":-8.546984,"twenty":-28.099524,"median":-18.253212,"eighty":-8.229013,"marketCap":663228854},{"date":"2022-08-12","current":5.525032,"twenty":-27.916011,"median":-18.196675,"eighty":-8.169153,"marketCap":623974964},{"date":"2022-08-19","current":5.315016,"twenty":-27.790849,"median":-17.942261,"eighty":-8.044899,"marketCap":600256617},{"date":"2022-08-26","current":5.173659,"twenty":-27.604011,"median":-17.905916,"eighty":-7.905239,"marketCap":584292346},{"date":"2022-09-02","current":5.331171,"twenty":-27.567722,"median":-17.603042,"eighty":-7.802077,"marketCap":602081106},{"date":"2022-09-09","current":5.476566,"twenty":-27.533288,"median":-17.215364,"eighty":-7.757032,"marketCap":618501499},{"date":"2022-09-16","current":5.044418,"twenty":-27.467722,"median":-16.000542,"eighty":-7.692862,"marketCap":569696440},{"date":"2022-09-23","current":4.773821,"twenty":-27.282953,"median":-14.986725,"eighty":-7.619589,"marketCap":539136263},{"date":"2022-09-30","current":5.177698,"twenty":-27.247701,"median":-14.001364,"eighty":-7.542033,"marketCap":584748468},{"date":"2022-10-07","current":5.092884,"twenty":-27.155388,"median":-13.666982,"eighty":-7.496604,"marketCap":575169905},{"date":"2022-10-14","current":5.096922,"twenty":-27.131736,"median":-13.168966,"eighty":-7.411233,"marketCap":575626027},{"date":"2022-10-21","current":4.959604,"twenty":-27.095178,"median":-12.656721,"eighty":-7.277453,"marketCap":560117877},{"date":"2022-10-28","current":5.500799,"twenty":-26.993906,"median":-12.400598,"eighty":-7.19113,"marketCap":621238232},{"date":"2022-11-04","current":5.024225,"twenty":-26.920032,"median":-11.991513,"eighty":-7.112385,"marketCap":567415830},{"date":"2022-11-11","current":4.963643,"twenty":-26.735211,"median":-11.923926,"eighty":-7.040872,"marketCap":560573999},{"date":"2022-11-18","current":5.385148,"twenty":-26.582437,"median":-11.831437,"eighty":-6.949546,"marketCap":568036129},{"date":"2022-11-25","current":5.762672,"twenty":-26.455235,"median":-11.753177,"eighty":-6.873368,"marketCap":607858162},{"date":"2022-12-02","current":5.254967,"twenty":-26.455235,"median":-11.532627,"eighty":-6.625211,"marketCap":554304393},{"date":"2022-12-09","current":5.055356,"twenty":-26.454618,"median":-11.326306,"eighty":-6.469392,"marketCap":533249065},{"date":"2022-12-16","current":4.964229,"twenty":-26.343884,"median":-11.169787,"eighty":-6.232777,"marketCap":523636850},{"date":"2022-12-23","current":4.443506,"twenty":-26.325326,"median":-11.105757,"eighty":-6.094271,"marketCap":468709908},{"date":"2022-12-30","current":4.578026,"twenty":-26.301065,"median":-11.016825,"eighty":-3.150451,"marketCap":482899368},{"date":"2023-01-06","current":4.716886,"twenty":-26.263087,"median":-10.952794,"eighty":4.412263,"marketCap":497546553},{"date":"2023-01-13","current":4.764619,"twenty":-25.896622,"median":-10.472565,"eighty":4.513804,"marketCap":502581522},{"date":"2023-01-20","current":3.966661,"twenty":-25.651649,"median":-10.436992,"eighty":4.53984,"marketCap":418411296},{"date":"2023-01-27","current":4.27609,"twenty":-25.609995,"median":-10.344504,"eighty":4.516407,"marketCap":451050523},{"date":"2023-02-03","current":4.387932,"twenty":-25.574321,"median":-10.280473,"eighty":4.484296,"marketCap":462847834},{"date":"2023-02-10","current":4.231353,"twenty":-25.545866,"median":-10.209328,"eighty":4.447845,"marketCap":446331599},{"date":"2023-02-17","current":4.227625,"twenty":-25.510604,"median":-10.152412,"eighty":4.446109,"marketCap":445938355},{"date":"2023-02-24","current":4.100871,"twenty":-25.479055,"median":-10.059923,"eighty":4.44283,"marketCap":432568070},{"date":"2023-03-03","current":4.287274,"twenty":-25.365847,"median":-9.946091,"eighty":4.430387,"marketCap":452230255},{"date":"2023-03-10","current":3.850903,"twenty":-25.237793,"median":-9.789572,"eighty":4.390734,"marketCap":428274275},{"date":"2023-03-17","current":4.031248,"twenty":-25.211811,"median":-9.714869,"eighty":4.386029,"marketCap":448331197},{"date":"2023-03-24","current":3.716528,"twenty":-25.128794,"median":-9.66151,"eighty":4.370626,"marketCap":413329901},{"date":"2023-03-31","current":3.617515,"twenty":-25.091983,"median":-9.576136,"eighty":4.334993,"marketCap":402318258},{"date":"2023-04-06","current":3.536182,"twenty":-25.085262,"median":-9.512105,"eighty":4.317099,"marketCap":393272980},{"date":"2023-04-14","current":3.606906,"twenty":-25.016947,"median":-9.44096,"eighty":4.305914,"marketCap":401138439},{"date":"2023-04-21","current":3.710993,"twenty":-25.016947,"median":-9.391159,"eighty":4.305914,"marketCap":412714374},{"date":"2023-04-28","current":3.420906,"twenty":-24.972406,"median":-9.152822,"eighty":4.291002,"marketCap":380452621},{"date":"2023-05-05","current":3.396142,"twenty":-24.931577,"median":-9.120807,"eighty":4.278327,"marketCap":377698569},{"date":"2023-05-12","current":5.794216,"twenty":-24.827649,"median":-9.066281,"eighty":4.278327,"marketCap":378652011},{"date":"2023-05-19","current":5.300322,"twenty":-24.781253,"median":-8.907372,"eighty":4.321573,"marketCap":346376060},{"date":"2023-05-26","current":5.758077,"twenty":-24.649487,"median":-8.823876,"eighty":4.401172,"marketCap":376290356},{"date":"2023-06-02","current":6.119463,"twenty":-24.464843,"median":-8.800111,"eighty":4.447845,"marketCap":399906906},{"date":"2023-06-09","current":7.830022,"twenty":-24.359983,"median":-8.721708,"eighty":4.553726,"marketCap":511691908},{"date":"2023-06-16","current":7.649329,"twenty":-24.335847,"median":-8.650275,"eighty":4.643117,"marketCap":499883633},{"date":"2023-06-23","current":7.462613,"twenty":-24.302442,"median":-8.521014,"eighty":4.676219,"marketCap":487681749},{"date":"2023-06-30","current":6.625403,"twenty":-24.270397,"median":-8.440219,"eighty":4.720357,"marketCap":432970076},{"date":"2023-07-07","current":6.312202,"twenty":-24.253567,"median":-8.382507,"eighty":4.781976,"marketCap":412502399},{"date":"2023-07-14","current":6.938604,"twenty":-24.246766,"median":-8.313516,"eighty":4.899023,"marketCap":453437752},{"date":"2023-07-21","current":6.583241,"twenty":-24.228208,"median":-8.252287,"eighty":4.955566,"marketCap":430214811},{"date":"2023-07-28","current":5.992978,"twenty":-24.153973,"median":-8.197862,"eighty":4.964229,"marketCap":391641114},{"date":"2023-08-04","current":6.029117,"twenty":-24.135415,"median":-8.143007,"eighty":5.024225,"marketCap":394002769},{"date":"2023-08-11","current":-3.101956,"twenty":-24.043543,"median":-8.079526,"eighty":5.037999,"marketCap":439739486},{"date":"2023-08-18","current":-3.038651,"twenty":-23.986946,"median":-7.961621,"eighty":5.024225,"marketCap":430765211},{"date":"2023-08-25","current":-3.349148,"twenty":-23.971475,"median":-7.900622,"eighty":5.024225,"marketCap":474781894},{"date":"2023-09-01","current":-3.120043,"twenty":-23.963398,"median":-7.814953,"eighty":5.00807,"marketCap":442303565},{"date":"2023-09-08","current":-3.195407,"twenty":-23.952543,"median":-7.796742,"eighty":4.991915,"marketCap":452987226},{"date":"2023-09-15","current":-2.906011,"twenty":-23.905288,"median":-7.750573,"eighty":4.97243,"marketCap":411961968},{"date":"2023-09-22","current":-2.896968,"twenty":-23.87925,"median":-7.721718,"eighty":4.965097,"marketCap":410679928},{"date":"2023-09-29","current":-2.921084,"twenty":-23.868287,"median":-7.675549,"eighty":4.96376,"marketCap":414098700},{"date":"2023-10-06","current":-2.601543,"twenty":-23.710456,"median":-7.619589,"eighty":4.963643,"marketCap":368799977},{"date":"2023-10-13","current":-2.628674,"twenty":-23.619487,"median":-7.55836,"eighty":4.960412,"marketCap":372646095},{"date":"2023-10-20","current":-2.580442,"twenty":-23.588336,"median":-7.537951,"eighty":4.956374,"marketCap":365808552},{"date":"2023-10-27","current":-2.562354,"twenty":-23.577201,"median":-7.537951,"eighty":4.95395,"marketCap":363244474},{"date":"2023-11-03","current":-2.833662,"twenty":-23.525109,"median":-7.490874,"eighty":4.945065,"marketCap":401705653},{"date":"2023-11-10","current":-2.627538,"twenty":-23.422263,"median":-7.46779,"eighty":4.934564,"marketCap":410266375},{"date":"2023-11-17","current":-2.457666,"twenty":-23.418281,"median":-7.346597,"eighty":4.924871,"marketCap":383742376},{"date":"2023-11-24","current":-2.400128,"twenty":-23.402351,"median":-7.300975,"eighty":4.899023,"marketCap":374758441},{"date":"2023-12-01","current":-2.243956,"twenty":-23.38188,"median":-7.252692,"eighty":4.894984,"marketCap":350373474},{"date":"2023-12-08","current":-2.219297,"twenty":-23.349573,"median":-7.190987,"eighty":4.882868,"marketCap":346523216},{"date":"2023-12-15","current":-2.331632,"twenty":-23.33342,"median":-7.139553,"eighty":4.789976,"marketCap":364063280},{"date":"2023-12-22","current":-2.597399,"twenty":-23.31266,"median":-7.102546,"eighty":4.781976,"marketCap":405560505},{"date":"2023-12-29","current":-2.80289,"twenty":-23.29604,"median":-7.064172,"eighty":4.777083,"marketCap":437645988},{"date":"2024-01-05","current":-2.865907,"twenty":-23.281729,"median":-7.040729,"eighty":4.771981,"marketCap":447485536},{"date":"2024-01-12","current":-2.852207,"twenty":-23.267192,"median":-6.96282,"eighty":4.75594,"marketCap":445346504},{"date":"2024-01-19","current":-2.890566,"twenty":-23.26073,"median":-6.945507,"eighty":4.721225,"marketCap":451335794},{"date":"2024-01-26","current":-3.561834,"twenty":-23.253883,"median":-6.873368,"eighty":4.716886,"marketCap":556148372},{"date":"2024-02-02","current":-4.797517,"twenty":-23.2365,"median":-6.682784,"eighty":4.712546,"marketCap":749089076},{"date":"2024-02-09","current":-4.929031,"twenty":-23.220347,"median":-6.561729,"eighty":4.68093,"marketCap":769623785},{"date":"2024-02-16","current":-5.049585,"twenty":-23.171887,"median":-6.506904,"eighty":4.669153,"marketCap":788447268},{"date":"2024-02-23","current":-4.805736,"twenty":-23.163249,"median":-6.426108,"eighty":4.668881,"marketCap":750372495},{"date":"2024-03-01","current":-5.060545,"twenty":-23.137421,"median":-6.232777,"eighty":4.658671,"marketCap":790158494},{"date":"2024-03-08","current":-4.479692,"twenty":-23.034584,"median":-6.129168,"eighty":4.638777,"marketCap":699463529},{"date":"2024-03-15","current":-4.754705,"twenty":-22.971586,"median":-6.023817,"eighty":4.599723,"marketCap":728240056},{"date":"2024-03-22","current":-4.594434,"twenty":-22.957936,"median":-5.1674,"eighty":4.58063,"marketCap":703692639},{"date":"2024-03-28","current":-4.98527,"twenty":-22.956946,"median":-5.066025,"eighty":4.565008,"marketCap":763553885},{"date":"2024-04-05","current":-4.690034,"twenty":-22.858149,"median":-5.049585,"eighty":4.553726,"marketCap":718334958},{"date":"2024-04-12","current":-4.884046,"twenty":-22.763209,"median":-4.994788,"eighty":4.533765,"marketCap":748050253},{"date":"2024-04-19","current":-5.078058,"twenty":-22.734133,"median":-4.994788,"eighty":4.513804,"marketCap":777765548},{"date":"2024-04-26","current":-5.412659,"twenty":-22.664804,"median":-4.993658,"eighty":4.472145,"marketCap":829013666},{"date":"2024-05-03","current":-7.754864,"twenty":-22.500405,"median":-5.013967,"eighty":4.447845,"marketCap":1187750489},{"date":"2024-05-10","current":-7.639581,"twenty":-22.395724,"median":-5.055065,"eighty":4.445242,"marketCap":1170093574},{"date":"2024-05-17","current":-10.368658,"twenty":-22.239842,"median":-5.071504,"eighty":4.441477,"marketCap":1372271111},{"date":"2024-05-24","current":-9.863507,"twenty":-22.137115,"median":-5.1674,"eighty":4.41091,"marketCap":1305415400},{"date":"2024-05-31","current":-9.924473,"twenty":-22.049888,"median":-5.362047,"eighty":4.390033,"marketCap":1313484192},{"date":"2024-06-07","current":-9.815605,"twenty":-21.837626,"median":-6.023817,"eighty":4.384126,"marketCap":1299075634},{"date":"2024-06-14","current":-9.493353,"twenty":-21.679323,"median":-6.111584,"eighty":4.370626,"marketCap":1256426301},{"date":"2024-06-21","current":-7.625166,"twenty":-21.588865,"median":-6.169295,"eighty":4.339467,"marketCap":1009175437},{"date":"2024-06-28","current":-7.442266,"twenty":-21.51456,"median":-6.232777,"eighty":4.33052,"marketCap":984969059},{"date":"2024-07-05","current":-7.307269,"twenty":-21.390179,"median":-6.388596,"eighty":4.314862,"marketCap":967102446},{"date":"2024-07-12","current":-7.045984,"twenty":-21.32627,"median":-6.506904,"eighty":4.305914,"marketCap":932521906},{"date":"2024-07-15","current":-7.163562,"twenty":-21.314052,"median":-6.544416,"eighty":4.305914,"marketCap":948083149},{"date":"2024-08-02","current":-8.169509,"twenty":-21.301833,"median":-6.544416,"eighty":4.305914,"marketCap":1081218229},{"date":"2024-08-09","current":-6.680107,"twenty":-20.625922,"median":-6.625211,"eighty":4.29473,"marketCap":949657379},{"date":"2024-08-16","current":-6.896252,"twenty":-20.070456,"median":-6.645442,"eighty":4.280564,"marketCap":980384999},{"date":"2024-08-23","current":-7.283682,"twenty":-19.824926,"median":-6.680107,"eighty":4.26938,"marketCap":1035462808},{"date":"2024-08-30","current":-7.691503,"twenty":-19.710238,"median":-6.763232,"eighty":4.255959,"marketCap":1093439449},{"date":"2024-09-06","current":-7.31223,"twenty":-19.603626,"median":-6.856262,"eighty":4.249994,"marketCap":1039521173},{"date":"2024-09-13","current":-7.185805,"twenty":-19.383942,"median":-6.939269,"eighty":4.247011,"marketCap":1021548414},{"date":"2024-09-20","current":-7.316308,"twenty":-19.267638,"median":-6.945507,"eighty":4.238063,"marketCap":1040100939},{"date":"2024-09-27","current":-7.055302,"twenty":-19.190102,"median":-6.948392,"eighty":4.229862,"marketCap":1002995889},{"date":"2024-10-04","current":-6.565917,"twenty":-19.114182,"median":-6.940945,"eighty":4.226134,"marketCap":933423920},{"date":"2024-10-11","current":-6.472118,"twenty":-19.093183,"median":-6.896252,"eighty":4.222406,"marketCap":920089292},{"date":"2024-10-18","current":-7.08385,"twenty":-19.049569,"median":-6.88481,"eighty":4.219245,"marketCap":1007054254},{"date":"2024-10-25","current":-6.46804,"twenty":-18.988186,"median":-6.839157,"eighty":4.217292,"marketCap":919509526},{"date":"2024-10-31","current":-6.614856,"twenty":-18.93488,"median":-6.835079,"eighty":4.216441,"marketCap":940381117},{"date":"2024-11-08","current":-6.292896,"twenty":-18.896112,"median":-6.798375,"eighty":4.21495,"marketCap":903276066},{"date":"2024-11-15","current":-6.206551,"twenty":-18.795962,"median":-6.724967,"eighty":4.198546,"marketCap":890882172},{"date":"2024-11-22","current":-4.957128,"twenty":-18.703889,"median":-6.705868,"eighty":4.156792,"marketCap":711541186},{"date":"2024-11-29","current":-5.456086,"twenty":-18.697427,"median":-6.672858,"eighty":4.156792,"marketCap":783161125},{"date":"2024-12-06","current":-5.046372,"twenty":-18.616661,"median":-6.663794,"eighty":4.149336,"marketCap":724351256},{"date":"2024-12-13","current":-4.949015,"twenty":-18.568201,"median":-6.634307,"eighty":4.138152,"marketCap":710376634},{"date":"2024-12-20","current":-4.441944,"twenty":-18.527818,"median":-6.623012,"eighty":4.123239,"marketCap":637592143},{"date":"2024-12-27","current":-5.232975,"twenty":-18.450282,"median":-6.614856,"eighty":4.123239,"marketCap":751135949},{"date":"2025-01-03","current":-5.02609,"twenty":-18.401822,"median":-6.606699,"eighty":4.123239,"marketCap":721439877},{"date":"2025-01-10","current":-4.514962,"twenty":-18.369515,"median":-6.569995,"eighty":4.121748,"marketCap":648073110},{"date":"2025-01-17","current":-4.113361,"twenty":-18.321055,"median":-6.553072,"eighty":4.116529,"marketCap":590427793},{"date":"2025-01-24","current":-4.283737,"twenty":-18.26775,"median":-6.542932,"eighty":4.109818,"marketCap":614883382},{"date":"2025-01-31","current":-4.454113,"twenty":-18.227367,"median":-6.508822,"eighty":4.100871,"marketCap":639338971},{"date":"2025-02-07","current":-4.198549,"twenty":-18.216059,"median":-6.498624,"eighty":4.100125,"marketCap":602655587},{"date":"2025-02-14","current":-3.89025,"twenty":-18.153061,"median":-6.472118,"eighty":4.085378,"marketCap":558402616},{"date":"2025-02-21","current":-3.711761,"twenty":-17.978606,"median":-6.46804,"eighty":4.03832,"marketCap":532782475},{"date":"2025-02-28","current":-2.995164,"twenty":-17.946299,"median":-6.420369,"eighty":4.031248,"marketCap":501339575},{"date":"2025-03-07","current":-2.974879,"twenty":-17.938223,"median":-6.366085,"eighty":3.966661,"marketCap":497944149},{"date":"2025-03-14","current":-3.118204,"twenty":-17.922069,"median":-6.285921,"eighty":3.96406,"marketCap":521934407},{"date":"2025-03-21","current":-3.04829,"twenty":-17.905916,"median":-6.206551,"eighty":3.914554,"marketCap":510231842},{"date":"2025-03-28","current":-2.897972,"twenty":-17.67977,"median":-6.129168,"eighty":3.907012,"marketCap":485071327},{"date":"2025-04-04","current":-2.618313,"twenty":-17.647464,"median":-6.023817,"eighty":3.892099,"marketCap":438261066},{"date":"2025-04-11","current":-2.649775,"twenty":-17.55862,"median":-5.539245,"eighty":3.889801,"marketCap":443527221},{"date":"2025-04-17","current":-2.660262,"twenty":-17.41001,"median":-5.456086,"eighty":3.867169,"marketCap":445282605},{"date":"2025-04-25","current":-2.845536,"twenty":-17.120867,"median":-5.342502,"eighty":3.855853,"marketCap":476294403},{"date":"2025-05-02","current":-2.978375,"twenty":-16.217699,"median":-5.304658,"eighty":3.85161,"marketCap":498529277},{"date":"2025-05-09","current":-2.565482,"twenty":-16.001965,"median":-5.232975,"eighty":3.848073,"marketCap":458543962},{"date":"2025-05-16","current":-2.390488,"twenty":-15.801336,"median":-5.186324,"eighty":3.841708,"marketCap":427266189},{"date":"2025-05-23","current":-2.605103,"twenty":-15.199448,"median":-5.14373,"eighty":3.821756,"marketCap":465625722},{"date":"2025-05-30","current":-2.865944,"twenty":-14.971784,"median":-5.103164,"eighty":3.81193,"marketCap":512247309},{"date":"2025-06-06","current":-2.885754,"twenty":-14.741273,"median":-5.086938,"eighty":3.806346,"marketCap":515788189},{"date":"2025-06-13","current":-2.955092,"twenty":-14.251795,"median":-5.078058,"eighty":3.788898,"marketCap":528181269},{"date":"2025-06-20","current":-2.694251,"twenty":-13.941602,"median":-5.060545,"eighty":3.760608,"marketCap":481559682},{"date":"2025-06-27","current":-2.558878,"twenty":-13.795043,"median":-5.047979,"eighty":3.727137,"marketCap":457363669}],"updateTime":1751252791840}}}